Basel Medical Group Ltd (BMGL) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 11, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F/A for FY2025, filed Mar 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BMGL SEC filings page.
Basel Medical Group Ltd (BMGL) reported $8.9M in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).
External financing is balancing heavy operating and investing cash use, while receivables make working-capital conversion central.
The earnings-to-cash gap is material: net loss was-$8.4M versus operating cash flow of-$3.2M , pointing to non-cash or timing effects rather than a one-for-one cash drain. Free cash flow of-$3.6M was only modestly below operating cash flow, so reinvestment was not the main source of cash pressure.
Accounts receivable of
Financing inflows of
Financial Health Signals
Basel Medical Group Ltd does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Basel Medical Group Ltd reported a net loss of $8.4M while operations used $3.2M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q4 2025.
Cash & Balance Sheet
Basel Medical Group Ltd held $2.4M in cash against $2.3M in long-term debt as of Q4 2025.
Not reported for Q4 2025.
Not reported for Q4 2025.
Margins & Returns
None of these metrics is reported for Q4 2025.
Capital Allocation
None of these metrics is reported for Q4 2025.
BMGL Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2520-F/A |
|---|
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
BMGL Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2520-F/A |
|---|---|
| Total Assets | $14.7M |
| Current Assets | $10.5M |
| Cash & Equivalents | $2.4M |
| Inventory | $385K |
| Accounts Receivable | $7.5M |
| Total Liabilities | $10.4M |
| Current Liabilities | $8.0M |
| Non-Current Liabilities | $2.4M |
| Long-Term Debt | $2.3M |
| Total Equity | $4.3M |
| Retained Earnings | -$2.7M |
Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments, Goodwill.
BMGL Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2520-F/A |
|---|
Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.
BMGL Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2520-F/A |
|---|---|
| Current Ratio | 1.31 |
| Debt-to-Equity | 0.54 |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Basel Medical Group Ltd BMGL | FY2025 | $8.9M | -$8.4M | -94.0% | $7.2M | — |
| Cryo-Cell Intl Inc CCEL | FY2025 | $31.6M | -$2.4M | -7.7% | $33.1M | 27/100 |
| Concord Medical CCM | FY2025 | $65.9M | -$13.3M | -20.2% | $17.9M | 29/100 |
| Amer Shared Hosp AMS | FY2025 | $28.1M | -$1.6M | -5.5% | $9.9M | 37/100 |
| Modivcare Inc MODV | FY2024 | $2.8B | -$201.3M | -7.2% | $6.2M | 20/100 |
| NewGenIvf Group NIVF | FY2025 | $4.7M | $9.9M | N/A | $2.3M | 31/100 |
Where Basel Medical Group Ltd Ranks
Frequently Asked Questions
What is Basel Medical Group Ltd's annual revenue?
Basel Medical Group Ltd (BMGL) reported $8.9M in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Is Basel Medical Group Ltd profitable?
No, Basel Medical Group Ltd (BMGL) reported a net income of -$8.4M in fiscal year 2025, with a net profit margin of -94.0%.
How much debt does Basel Medical Group Ltd have?
As of fiscal year 2025, Basel Medical Group Ltd (BMGL) had $2.4M in cash and equivalents against $2.3M in long-term debt.
What is Basel Medical Group Ltd's net profit margin?
Basel Medical Group Ltd (BMGL) had a net profit margin of -94.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Basel Medical Group Ltd's return on equity (ROE)?
Basel Medical Group Ltd (BMGL) has a return on equity of -195.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Basel Medical Group Ltd's free cash flow?
Basel Medical Group Ltd (BMGL) recorded an outflow of $3.6M in free cash flow during fiscal year 2025. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Basel Medical Group Ltd's operating cash flow?
Basel Medical Group Ltd (BMGL) recorded an outflow of $3.2M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Basel Medical Group Ltd's total assets?
Basel Medical Group Ltd (BMGL) had $14.7M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Basel Medical Group Ltd's capital expenditures?
Basel Medical Group Ltd (BMGL) invested $438K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Basel Medical Group Ltd's current ratio?
Basel Medical Group Ltd (BMGL) had a current ratio of 1.31 as of fiscal year 2025, which is considered adequate.
What is Basel Medical Group Ltd's debt-to-equity ratio?
Basel Medical Group Ltd (BMGL) had a debt-to-equity ratio of 0.54 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Basel Medical Group Ltd's return on assets (ROA)?
Basel Medical Group Ltd (BMGL) had a return on assets of -56.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Basel Medical Group Ltd's P/E ratio?
Basel Medical Group Ltd (BMGL) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $7.2M as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Basel Medical Group Ltd's price-to-sales ratio?
Basel Medical Group Ltd (BMGL) trades at 0.8x sales, its market capitalization divided by revenue of $8.9M revenue, FY2025. The market capitalization is $7.2M as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Are Basel Medical Group Ltd's earnings high quality?
Basel Medical Group Ltd (BMGL) reported a net loss of $8.4M while operations used $3.2M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.